The invention relates to a particular cosmetic active substance that is constituted through bioconversion by Lactobacillus arizonensis of its original substrate, Simmondisia chinens. The invention also relates to a preparation method, to compositions comprising same, and to uses thereof for cosmetic applications.

A Ganoderma lucidum polysaccharides composite composition comprising, based on a total composition: 1 to 5 wt. % β-glucan extract, 1 to 5 wt. % Ganoderma lucidum mycelium extract, 1 to 5 wt. % Trametes versicolor mycelium extract, 1 to 5 wt. % Tremella fuciformis Berk extract, 1 to 5 wt. % Auricularia auricula-judae extract, 1 to 5 wt. % Hericium erinaceus extract, 1 to 3 wt. % Ganoderma lucidum fruiting body extract, and water.

Described herein are mushroom compositions and methods for treating, prophylaxis of, or ameliorating symptoms of one or more adverse reactions triggered by an infectious disease or condition that increases an anti-inflammatory response in a subject with such compositions. In one aspect the composition comprises an aqueous or solid fraction of a mycelium, a fermented substrate thereof, or a combination thereof optionally combined with one or more buffering agents, ethanol, and water.

Methods are provided for producing cannabidiol (CBD)-based products in accordance with cycles of the moon and a plurality of biodynamic rituals. In some embodiments, the phase of the moon may be correlated with positions of the moon among the twelve zodiac signs, and the positions used to guide in the cultivation and harvest of cannabis plants. In some embodiments, the phase of the moon and the corresponding astrological phase that the moon is moving through may be used to determine when to plant seeds, when/how to water and fertilize, when to take cuttings, and the right time to harvest mature cannabis plants to produce optimal CBD containing products. Additional methods prior to and during the extraction process may lead to better producing and/or tasting products. It is contemplated that farming cannabis with consideration of moon cycles and various cleansing processes may result in healthier plants, increased yields, and superior products.

Disclosed is a root extract from plants of the Morus genus (in particular Morus albaet, Morus nigra) that is rich in prenylated polyphenols chosen from: moracenin A, moracenin B, kuwanon C, wittiorumin F and mulberrofuran T, a method for preparing such an extract and a cosmetic composition and a pharmaceutical or nutraceutical composition, the compositions including, as the active ingredient, at least one root extract from plants of the Morus genus according to the invention.

The present invention provides a novel use of Morchella active substance. The Morchella active substance is for manufacturing a composition for ameliorating Sarcopenia. The preparation method of the Morchella active substance comprises the following steps: (a) culturing Morchella mycelium in a plate media between 15° C. and 30° C. for 1 to 2 weeks; (b) inoculating the Morchella mycelium cultured in step (a) to a flask and culturing the Morchella mycelium between 15° C. and 30° C. with a pH of 2 to 6 for 4 to 7 days; and (c) inoculating the Morchella mycelium cultured in step (b) to a fermentation tank and culturing the Morchella mycelium between 15° C. and 30° C. with a pH of 2 to 6 for 6 to 10 days, so as to obtain a Morchella mycelium fermentation broth containing the Morchella active substance.

The invention provides a method for improving sarcopenia of a subject in need thereof by using Phellinus linteus, in which the method includes administering an effective dose of composition to the subject, and the composition includes Phellinus linteus (NITE BP-03321 and BCRC 930210) as an effective substance. By using the aforementioned composition including an extract of a fermented product of the Phellinus linteus and/or its derivative, diameters of myotubes, amounts of muscles and muscle muscular endurance can be maintained, thereby improving sarcopenia.

Provided are aqueous Alerce (Fitzroya cupressoides) cell extracts, which may be obtained from in vitro cultures of Alerce cells. The aqueous Alerce cell extracts promote cell regeneration, and therefore have anti-aging properties. The Alerce cell extracts have been found to have no toxic effects on human cells, and have been found to not boost skin cancer cells. Such extracts may be used in pharmaceutical or cosmetic formulations for skin care, especially to promote regeneration and/or anti-aging of the skin.

The present specification discloses one or more anti-oncogenic phytochemicals, extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals disclosed herein, methods of preparing extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals, extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals prepared according to methods disclosed herein, and methods and uses for treating a neoplasm or a cancer using one or more anti-oncogenic phytochemicals as well as extracts, pharmaceutical compositions and medicaments comprising one or more anti-oncogenic phytochemicals disclosed herein.

The present invention is related to an active substance of Hericium erinaceus having a pain-relieving effect, and a pharmaceutical composition including the active substance. The active substance is prepared using the following steps: (a) inoculating a mycelium of H. erinaceus on an agar plate and incubating at 15-32° C. for 8-16 days; (b) inoculating the incubated H. erinaceus mycelia from step (a) into a medium in a flask and incubating at 20-30° C. and pH 4.5-6.5 for 3-5 days; (c) inoculating the incubated H. erinaceus mycelia from step (b) into a medium in a fermentation tank and incubating at 24-32° C. and pH 4.5-5.5 for 8-16 days to obtain a fermented medium of the H. erinaceus mycelia; and (d) desiccating the fermented medium of the H. erinaceus mycelia from step (c) to obtain the powder of the H. erinaceus mycelia, which is further purified and isolated to obtain a novel compound of H. erinaceus.